MOA: inhibits mycolic acid synthesis (bactericidal)
PK: metabolised in liver through acetylation (rate is genetic characteristic)
Adverse reactions: peripheral neuropathy (pyridoxine), hepatitis (>35yrs), severe hypersensitivity (rash, fever, arthritis), neurotoxicity (ataxia, seizures, psychosis - dose-related)